Biguanides
Biguanides
Biguanides (pronunciation: bi-gwan-ides) are a class of medications used primarily for the management of Type 2 diabetes. They function by reducing the amount of glucose produced by the liver and by making the body more sensitive to insulin.
Etymology
The term "biguanide" is derived from its chemical structure, which consists of two (bi-) guanidine groups. Guanidine itself is a compound that was first isolated from the plant Galega officinalis, also known as French lilac or goat's rue.
Types of Biguanides
There are three types of biguanides: Phenformin, Buformin, and Metformin. Of these, Metformin is the most commonly prescribed and is considered the first-line treatment for Type 2 diabetes.
Phenformin
Phenformin was used from the 1950s through the 1970s, but was discontinued due to its association with lactic acidosis, a serious and potentially fatal side effect.
Buformin
Buformin, like Phenformin, was associated with an increased risk of lactic acidosis and has been withdrawn from many markets.
Metformin
Metformin is currently the most widely used biguanide, with a better safety profile than its predecessors. It is used not only for the treatment of Type 2 diabetes, but also for Polycystic ovary syndrome (PCOS) and in some cases, prediabetes.
Side Effects
Common side effects of biguanides include gastrointestinal issues such as nausea, vomiting, and diarrhea. More serious side effects can include lactic acidosis, particularly in patients with kidney problems.
Related Terms
External links
- Medical encyclopedia article on Biguanides
- Wikipedia's article - Biguanides
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski